Advocacy

Latest News

Advocacy in Action: March 12

March 12, 2024
 
  

February 1, Special Multistakeholder Committee Debrief 

Health Canada provided stakeholders with more information on Florida's bulk importation proposal and the associated regulatory measures the government is enacting to minimize its impact Canadians. CSHP CPO Rita Dhami expressed her concerns about the proposal, highlighting the potential consequences for certain patient groups and called for increased protection of a Vulnerable Drugs List. 

February 1, Choosing Wisely Canada Meeting of the Associations and Societies 

CSHP participated in the Meeting of the Associations and Societies hosted by Choosing Wisely Canada. The meeting's main agenda revolved around developing a handbook addressing climate change with an emphasis on hospital pharmacy-based recommendations. CSHP and CPhA will be collaborating to craft recommendations relevant to the pharmacy sector.

February 5, ASOP Canada FDA Drug Importation Letter to Minister Holland 

Following up the Special Multistakeholder Committee Debrief on February 1, CSHP cosigned a letter alongside members of ASOP Canada that requested further meetings to discuss gaps identified in the current regulatory framework. 

February 8, Drug Shortages Expert Review Panel

As part of a multistakeholder panel, CSHP is working to develop a framework to assess the clinical and supply chain risk of certain drugs. In turn, this tool will aid in creating a systematic, adaptable, transparent, and regularly updated National Vulnerable Drugs List. For information on the status of this project, please view CADTH’s health technology review.

Ongoing, Health Canada Drug Shortages Meetings

CSHP is continuing to monitor these ongoing drug shortages:

  • February 22 : Health Canada Meeting on Shortages of Semaglutide (Ozempic): –  CSHP is actively engaged in multistakeholder meetings with Health Canada to oversee the supply of Ozempic. Despite ongoing efforts to enhance and stabilize the situation, intermittent delays may persist for Canadians due to sustained high global demand.
  • February 26: Tier Assignment Committee (Propofol Injectable) – Health Canada is closely monitoring the propofol supply situation and has designated it as a Tier 3 shortage, indicating its significant potential impact on Canada's drug supply and healthcare system. It will be listed on the shortages list accordingly.
  • February 27: Tier Assignment Committee (Thiamine Injectable)–  Both market authorization holders in Canada, Omega and Sandoz, are reporting a shortage of Thiamine Hydrochloride Injectable. This shortage has been classified as Tier 3, prompting the drug shortages unit to seek foreign-authorized supply to address the issue.

To catch up on CSHP advocacy news, click here.

Have a question about Advocacy in Action or CSHP's advocacy and consultation work?
Reach out to our professional practice team!   

March 12, 2024
Advocacy in Action: March 12

Latest News

CSHP's statement on FDA’s Approval of Canadian Drug Importation

January 16, 2024
 
 
 
On January 5, the U.S. Food and Drug Administration (FDA) authorized Florida’s plan to import prescription drugs from Canada in an effort to reduce the drug costs to the American consumer. The Canadian Society of Hospital Pharmacists (CSHP) remains opposed to any exportation of medicines from Canada and will ramp up our advocacy to the U.S. Federal and state governments, as well as the FDA, to address the underlying drivers of drug shortages and pricing in the U.S.

“Canada cannot stock America’s medicine cabinet,” says CSHP President Ashley Walus. “Our drug supply is not the answer to the problem of high drug prices in the United States.”

The American Society of Health-System Pharmacists (ASHP) also acknowledges that drug importation from Canada is not a real solution because it is not a meaningful response to drug pricing and has the potential to disrupt the pharmacist-patient relationship. 

While the details of Florida’s plan are still to be released, Canada took precautionary steps in August 2021 in response to various states exploring legislation to import prescription drugs. Health Canada bolstered the existing limitations in our healthcare legislation to stipulate that pharmaceuticals intended for the domestic market cannot be distributed outside of Canada if it will cause or exacerbate a shortage of a drug.

“The intention of some U.S. states to tap into Canada’s supply isn’t new,” says CSHP CEO Jody Ciufo. “In 2019, CSHP joined the Alliance for Safe Online Pharmacies Canada (ASOP Canada) along with 12 other organizations to advocate against the export of Canadian drugs. We appeared before various state legislatures, met with U.S. federalrepresentatives, and featured prominently in media stories about the issue – and will do this again to actively protect our drug supply.”

CSHP is engaged with Health Canada and applauds their notification to regulated parties of their legal obligations not to distribute drugs for consumption outside of Canada if the distribution will cause or worsen a shortage of the drug. Just as important is their plan to enforce existing regulations: “The Department will not hesitate to take immediate action to address non-compliance, ranging from requesting a plan for corrective measures, issuing a public advisory or other forms of communication, to taking action on the licenses of regulated parties who contravene the export prohibition if warranted.”

Along with these safeguards, CSHP believes in the importance of these collective efforts to address the complexities associated with drug importation and its potential impact on patient care. “We are aligned with our peers including CPhA, are a member of ASOP Canada, and we will continue to safeguard the supply chain intended for Canadian patients,” says CSHP President Ashley Walus.

For more information please contact: Dr. Rita Dhami, Chief Pharmacy Officer at rdhami@cshp.ca.
January 16, 2024
CSHP's statement on FDA’s Approval of Canadian Drug Importation

Latest News

Advocacy in Action: December 5

December 5, 2023
 
  

What's happened

November 22, Choosing Wisely Canada Consultation 

CSHP provided feedback on Choosing Wisely Canada’s clinical biochemistry recommendations which will ultimately be released in early 2024 by the Canadian Society of Clinical Chemists.   

November 27, Drug Shortages Expert Review Panel

CPO Rita Dhami officially joined a panel of experts representing various pharmacy sectors that will be contributing to a CIHR-funded project. This collaborative initiative is led by the University of Toronto, Health Canada, and CADTH, with the goal of creating a systematic, adaptable, transparent, and regularly updated national list of at-risk medicines. 

November 30, Natural Health Products Consultation 

CSHP is providing ongoing feedback on the first round of new and updated natural health product monographs as part of the implementation of the new Natural Health Product (NHP) labelling initiative. This Natural and Non-Prescription Health Product Directoriate (NNHPD) led project is currently in its first round of consultations where CSHP is focused on accessing the accuracy, conciseness, and consistency of statements in their monographs. 

Ongoing, Health Canada Drug Shortages Meetings

CSHP is continuing to monitor these ongoing drug shortages:

  • Nov 16: Tier Assignment Committee –  Lidocaine/Bupivicaine (with and without Epinephrine)
  • Nov 22: Multi-Stakeholder Call – Shortages of Amoxicillin
  • Dec. 1: Multi-Stakeholder Call –  Lidocaine/Bupivicaine (with and without Epinephrine)

What's happening

December 5, Multilateral Meeting with Health Canada / Marketed Health Products Directorate

The CSHP Executive team, alongside our partners at A.P.E.S. and several other key stakeholders, will be participating in a multilateral meeting with Health Canada. This meeting will provide us with updates from the various divisions of Health Canada including the Marketed Health Products Branch, Pharmaceutical Drugs Directorate, and Biologic and Radiopharmaceutical Drugs Directorate.

December 15, Consultation Canadian Council of Accreditation for Pharmacy Programs – Pharmacy technicians    

CSHP was invited to consult and provide feedback on the Canadian Council of Accreditation for Pharmacy Programs’ first draft on their updated standards for pharmacy technicians programs.  

What's worth repeating

October, Health Canada consultation on the Handbook for healthcare professionals on biosimilar biologic drugs

Professional Practice Specialist Kiet-Nghi Cao joined a working group of subject matter consultants from across the country to help with the development of a Health Canada handbook focused on informing and educating healthcare professionals on biosimilars. The guidelines will provide background on the immunogenicity of biosimilars, details on authorization, accessibility, and monitoring of them, and includes example case studies. This handbook is now available and can be found here

To catch up on CSHP advocacy news, click here.

Have a question about Advocacy in Action or CSHP's advocacy and consultation work?
Reach out to our professional practice team!   

December 05, 2023
Advocacy in Action: December 5

Latest News

Advocacy in Action: November 7

November 7, 2023
 
  

What's happened

October 16, CSHP-CASCADES Exploring Collaboration Opportunities on Sustainability in Hospital Pharmacy 

After the successful launch of the Playbook on Climate Resilient, Low Carbon Sustainable Pharmacy with CSHP as a proud collaborator, Professional Practice team met with CASCADES to explore further potential collaborations focusing on sustainability practices in hospital pharmacy.

October 24, Mohawk-Medbuy Presentation on Sustainability in Hospital Pharmacy

CPO Rita Dhami attended the annual Pharmacy Committee Meeting at Mohawk-Medbuy where she shared recommendations from the CSHP Sustainability Task Force. Rita also highlighted the opportunities hospital pharmacy's clinical and operations teams can take to integrate sustainable considerations into procurement and practices. 

October, Health Canada consultation on the Handbook for healthcare professionals on biosimilar biologic drugs 

Professional Practice Specialist Kiet-Nghi Cao joined a working group of subject matter consultants from across the country to help with the development of a Health Canada handbook focused on informing and educating healthcare professionals on biosimilars. The guidelines will provide background on the immunogenicity of biosimilars, details on authorization, accessibility, and monitoring of them, and includes example case studies. This handbook is due to be released next month. 

Ongoing, Health Canada Drug Shortages Meetings

CSHP is continuing to monitor these ongoing drug shortages:

 

  • Oct 16: Multi-Stakeholder Call – Supply disruptions of Ozempic 
  • Oct 18: Multi-Stakeholder Call – Shortages of Amoxicillin oral 
  • Oct 27: Multi-Stakeholder Call – Supply disruptions of Ozempic
  • Nov 1: Clinical Stakeholders Call – Supply disruptions of Ozempic 
  • Nov 2: Tier Assignment Committee – Review of de-escalation of Erwinase 

What's worth repeating

October 5, Roundtable on Meeting of the Health Product Supply Chain Advisory Committee 

The Drug Shortages Task Force, including Rita and Assistant Deputy Minister Stefania Trombetti, met for a roundtable discussion. Deputy Minister Trombetti provided stakeholders with an overview of the consultation results on public drug shortages and informed committee members that Health Canada would develop a summary 'What we heard' document that would be shared with them soon.  

October 6, Collaboration on a National ‘At-Risk Medicines’ List   

As part of a CIHR-funded project with Health Canada and CADTH, Rita will join an expert panel to develop a national at-risk medicine list. 


To catch up on CSHP advocacy news, click here.

Have a question about Advocacy in Action or CSHP's advocacy and consultation work?
Reach out to our professional practice team!   

November 07, 2023
Advocacy in Action: November 7

Latest News

2023 AGM Weekend Recap – Meet the new CSHP President, Board members and task forces! 

November 7, 2023
 
 
From October 20 to 22, CSHP held Board meetings and its Annual General Meeting in Montréal.
 
Throughout the weekend Board members, Executive members, Branch presidents, and CSHP staff had plenty of discussions on priority topics for CSHP and hospital pharmacy. Keep reading to learn what happened! 

 

Board of Directors changes

 

The Board saw a few changes over AGM weekend. Very notable was the departure of CSHP National Board of Directors stalwart, Zack Dumont; he took his final bows after more than a decade of demanding work on the Board of Directors- and Saskatchewan Branch leadership before that. Throughout his tenure, Zack has touched everything from a pharmacy technician task force to being an expert and speaker for CSHP’s Hospital Pharmacy 101 to being a co-chair of the Vision for the Hospital Pharmacy Profession Task Force, and much more. His dedication and knowledge on top of his unprecedented two-year presidency where he led CSHP through a time of uncertainty. CSHP is incredibly grateful to Zack who remains committed to CSHP with his presence on committees, serving as Saskatchewan Branch’s secretary and, as of AGM weekend, as a proud CSHP Fellow! 

Other moves on the Board include Sean Spina taking up the Past President mantle after leading CSHP through the end of the 2020-2023 strategic plan. Ashley Walus was promoted to the President position where she will be focused on incorporating CSHP’s vision for hospital pharmacy into the next strategic plan. Katie Hollis officially stepped into her role as President-Elect. As for representation from the Branches, CSHP bid adieu to the now-former New Brunswick Delegate Chantal Michaud along with former Student Delegate Abby Krupski and then welcomed New Brunswick’s new delegate Timothy MacLaggan and Student Delegate Jacqueline Tian-Tran from the University of Saskatchewan.

 

Task forces

Vision for the Hospital Pharmacy Profession Task Force
The Vision for the Hospital Pharmacy Profession Task Force crafted 12 outstanding vision statements unanimously approved by the Board. They are as follows:

  1. Pharmacy professionals engage in shared decision-making to provide evidence-informed care that incorporates patients' values, needs, and preferences.
  2. Pharmacy professionals provide equitable, culturally appropriate care tailored to the populations they serve. 
  3. Pharmacy professionals collaborate to address patients' medication needs across the continuum of care.  
  4. Pharmacy professionals engage patients and their caregivers in managing the patient's health and wellness. 
  5. Pharmacy professionals optimize patient care by practicing with their full and expanding scope of responsibilities. 
  6. Pharmacy professionals develop and maintain leadership skills to benefit their patients, themselves, and the profession. 
  7. Pharmacy professionals meet complex practice needs in healthcare systems by engaging in formal training opportunities, including specialization and credentialling. 
  8. Pharmacy professionals are engaged in the education and mentorship of peers, future hospital pharmacy professionals, and other health care providers. 
  9. Pharmacy professionals pursue innovative solutions to improve access and provide care to patients in the most appropriate location, which may include their homes or local communities. 
  10. Pharmacy professionals lead quality improvement and research initiatives with a focus on medication use, pharmacy practice, and resource allocation. 
  11. Pharmacy professionals lead and implement rational medication use practices that are fiscally and environmentally sustainable. 
  12. Pharmacy professionals promote diversity, equity, inclusion, accessibility, and belonging, both within the pharmacy profession and the broader healthcare system. 

In a task force led by Co-Chairs Zack Dumont and Mary Gunther, these statements were narrowed down over a three-round process through a Delphi panel. On this panel, there were representatives from patient advocacy, IPPC, APES, CAPSI, Technicians, AFPC, 2SLGBTQA+ advocacy, and, for the first time, patients.  

With these statements agreed upon by the Board, this task force has been dissolved and will be replaced with a Vision Implementation Task Force. This new task force will concentrate on a plan to put the proposed work into practice in line with the approved vision statements.

Sustainability Task force
The Sustainability Task Force produced a set of short-term and long-term recommendations covering various aspects of CSHP work. This work will include: 

  • Advocacy & partnership 
  • Education 
  • Policy and procedure development 
  • Research and quality improvement 
  • Branding.

These recommendations advocate to Accreditation Canada, NAPRA, plus federal and provincial governments for the inclusion of environmental sustainability criteria, standards, and practices.  

They also plan for the creation of a planetary health education series, guideline development for sustainable conferences, and establishing a dedicated sustainability section on the CSHP website.  

This task force was also dissolved and is being replaced by a Sustainability Implementation Task Force. With several fresh faces on board, the new task force will be putting these approved recommendations into action.

The cornerstone of progress

On top of these changes, Board members and Branch presidents were able to take in highly anticipated updates from CSHP’s Year in Review. Topping out the list was continuous membership growth and brand-new non-dues revenue sources. The Hospital Pharmacy in Canada Survey Report is now more accessible than ever through multiple webinars, conference sessions, etc. Hospital Pharmacy 101 program sales continue to climb. These and other promising developments will be presented in CSHP’s upcoming 2022-23 Annual Report – so stay tuned to see how the past year has set the stage for great things from CSHP! 

November 07, 2023
2023 AGM Weekend Recap – Meet the new CSHP President, Board members and task forces!

Latest News

Advocacy in Action: October 10

October 10, 2023
 
  

What's happened

September 26, Alliance for Safe Online Pharmacies member meeting

The Alliance for Safe Online Pharmacies (ASOP Canada), known for its research, education, advocacy, and policy efforts, strives to address the growing threat of illegal online drug sellers to public health. CSHP CPO Rita Dhami attended one of their member meetings at the end of September to learn more about ASOP’s government engagement plans and results from their recent survey in addition to being told about their plans for a toolkit. 

October 5, Roundtable on Meeting of the Health Product Supply Chain Advisory Committee

The Drug Shortages Task Force, including Rita and Assistant Deputy Minister Stefania Trombetti, met again for a roundtable discussion. Deputy Minister Trombetti provided stakeholders with an overview of the consultation results on public drug shortages and informed committee members that Health Canada would develop a summary 'What we heard' document that would be shared with them soon. 

October 6, Collaboration on a National ‘At-Risk Medicines’ List 

As part of a CIHR-funded project with Health Canada and CADTH, Rita will join an expert panel to develop a national at-risk medicine list.   

Ongoing, Health Canada Drug Shortages meetings

CSHP is continuing to monitor these ongoing drug shortages:

  • Sept. 28: Multi-Stakeholder Call #15 – Shortages of Paediatric Analgesics 
  • Sept. 29: Multi-Stakeholder Call #3 – Supply disruptions of Ozempic  

What's worth repeating

September 12, Appropriate Use Advisory Committee Interim Report Roundtable

A unified appropriate-use program is being developed by the Canadian Drug Agency (CDA) to improve the pharmaceutical landscape. During this interim report roundtable, Rita spoke about the importance of promoting evidence-based approaches and interventions to improve the pharmaceutical industry. In addition to identifying drivers of inappropriate use, hospital pharmacy teams also employ multi-pronged behaviour change strategies in order to improve prescribing.

September 14, European Association of Hospital Pharmacists

President Sean Spina, CEO Jody Ciufo, and CPO Rita Dhami met with Ambassadors from the European Association of Hospital Pharmacists (EAHP) where EAHP introduced their organization and its strategic priorities. Over the course of this meeting, both organizations found several areas of overlap in their work including a shared focus on vision for practice, drug shortages, sustainability, and human resource challenges. It is expected that this meeting will be the first of many collaborations between CSHP and EAHP. 


To catch up on CSHP advocacy news, click here.

Have a question about Advocacy in Action or CSHP's advocacy and consultation work?
Reach out to our professional practice team!   

October 10, 2023
Advocacy in Action: October 10

Latest News

National Day for Truth and Reconciliation 2023

September 30, 2023
 
 
IPPC, CSHP, CPhA and CAPSI are proud to have shared commitments towards Truth and Reconciliation for pharmacy practice.

In the spirit of this commitment,we've posted this collaborative content to serve as a resource for years to come.

Originally posted on Sept. 25, 2023





Originally posted on Sept. 27, 2023


  


Originally posted on Sept. 28, 2023


 

 


Originally posted on Sept. 29, 2023


  


Originally posted on Sept. 30, 2023


 


Originally posted on Sept. 30, 2023


  

September 30, 2023
National Day for Truth and Reconciliation 2023

Latest News

Advocacy in Action: September 26

September 26, 2023
 
  

What's happened

September 1, Roundtable on Improving Canada’s Medical Countermeasure Readiness for Health Emergencies 

CPO Rita Dhami participated in a roundtable with Deputy Minister Stephen Lucas and spoke on how to improve Canada's medical countermeasure preparedness for future health emergencies. Rita covered hospital pandemic preparedness plans including interdepartmental key accountabilities and critical paths. Additionally, she stressed the importance of coordination among all healthcare providers across Canada, as well as the importance of public communication and education. 

September 12, Appropriate Use Advisory Committee Interim Report Roundtable 

A unified appropriate-use program is being developed by the Canadian Drug Agency (CDA) to improve the pharmaceutical landscape. During this interim report roundtable, Rita spoke about the importance of promoting evidence-based approaches and interventions to improve the pharmaceutical industry. In addition to identifying drivers of inappropriate use, hospital pharmacy teams also employ multi-pronged behaviour change strategies in order to improve prescribing. 

September 14, European Association of Hospital Pharmacists meeting 

Canadian Society of Hospital Pharmacists (CSHP) President Sean Spina, CEO Jody Ciufo, and CPO Rita Dhami met with Ambassadors from the European Association of Hospital Pharmacists (EAHP) where EAHP introduced their organization and its strategic priorities. Over the course of this meeting, both organizations found several areas of overlap in their work including a shared focus on vision for practice, drug shortages, sustainability, and human resource challenges. It is expected that this meeting will be the first of many collaborations between CSHP and EAHP.

Ongoing, Health Canada Drug Shortages meetings

CSHP is providing weekly feedback and amplifying the voice of hospital pharmacy on drug shortages.

  • Sept. 15: Multi-Stakeholder Call #2 – Supply disruptions of Ozempic 
  • Sept. 20: Multi-Stakeholder Call #12 – Shortages of Amoxicillin Oral Suspension/Capsules/Tablets

What's happening 

September 25, Canadian Nosocomial Infection Surveillance Program

CSHP will be attending a meeting regarding the Canadian Nosocomial Infection Surveillance program, a collaboration between the Public Health Agency of Canada (PHAC) and the National Microbiology Laboratory (NML), which will be addressing the program’s Antimicrobial Medication Use data in hospitals. The meeting will also highlight protocols and current advocacy to bring new antimicrobials to Canada. As advocates for antimicrobial stewardship, CSHP looks forward to being updated on these topics and their impact on hospital pharmacy.  

What's worth repeating

August 30, Drug Shortages Consultation has been submitted

CSHP’s submission provided four fundamental pillars that serve as a blueprint for collaborative action between Health Canada and fellow stakeholders. View the submission here.

To catch up on CSHP advocacy news, click here.

Have a question about Advocacy in Action or CSHP's advocacy and consultation work?
Reach out to our professional practice team!   

September 26, 2023
Advocacy in Action: September 26

Latest News

Advocacy in Action: August 29

August 29, 2023
 
  

What's happened

August 22, Roundtable meeting with Assistant Deputy Minister Stefania Trombetti

CEO Jody Ciufo and CPO Rita Dhami participated alongside Assistant Deputy Minister for Health Canada, Stefania Trombetti, the National Association of Pharmacy Regulatory Authorities (NAPRA), and the Canadian Paediatric Society. Solutions to improve access to drugs and other healthcare products in Canada were discussed. CSHP highlighted key aspects of our drug shortages consultation (read below).

August 23, Canadian Medical Association (CMA) 'Net Zero' meeting

Rita Dhami met with CMA Lead Sarah Lowden to explore collaboration opportunities to achieve a more sustainable healthcare system. 

August 24, Canadian Healthcare Workforce Network meeting 

Ivy Bourgeault and Dr. Natalie Crown, Project Leads of Health Human Resources initiatives, met with Rita to discuss their success in developing a toolkit to help health workers cope with burnout and an upcoming research opportunity pertaining to pharmacy health human resources.

August 25, Letter to Hon. Minister of Health Mark Holland

Jody Ciufo’s letter introduces CSHP and conveys the Society’s commitment to working with Minister Holland to promote the highest standards of healthcare and patient well-being in Canada.

Ongoing, Health Canada Drug Shortages meetings

CSHP is providing weekly feedback and amplifying the voice of hospital pharmacy on drug shortages

  • Aug 16: Multi-Stakeholder Call #11 – Shortages of Amoxicillin Oral Suspension/Capsules/Tablets 
  • Aug 23: Multi-Stakeholder Call – Impending supply disruptions of Ozempic 
  • Aug 24: Tier Assignment Committee Meeting – Potassium Chloride, Calcium Chloride, Dextrose 50% 
  • Aug 25: Tier Assignment Committee Review – Hydralazine and Primene 10% 

What's happening 

August 30, Drug Shortages Consultation to be submitted

CSHP’s submission provides four fundamental pillars that serve as a blueprint for collaborative action between Health Canada and fellow stakeholders.

  • Improved communication and transparency
    • Improved two-way communication and transparency from hospitals and manufacturers 
    • Earlier identification process for shortages and turn-around to Tier Assignment Committee 
  • Agile regulatory toolbox
    • Reassessment of outsourced drug preparation (previously known as commercial compounding) legislation to inform where compounding can support shortages 
  • Greater supply chain visibility  
    • Development of harmonized barcoding standards 
  • Enhanced response to supply and demand
    • Coordination of collaboration between CSHP and Medical Organizations to develop tools/resources to support hospital clinicians during shortages
    • Development of ethical framework to respond to shortages and prioritize patients consistently 

What's worth repeating

Tier 3 shortage: Hydrocortisone Injections

On August 2,  Solu-Cortef® was deemed a Tier 3 shortage and was posted on the Tier 3 drug shortages list. While the shortage of the 100mg strength has ended and the estimated end dates for the 500mg and 1g injections remain the same, the 250mg shortage has been extended to September 11.

To catch up on CSHP advocacy news, click here.

Have a question about Advocacy in Action or CSHP's advocacy and consultation work?
Reach out to our professional practice team!   

August 29, 2023
Advocacy in Action - August 29

Latest News

Advocacy in Action: August 15

August 15, 2023
 
  

Ongoing, Health Canada Drug Shortages  

 

CSHP is taking action to build a safer, more sustainable, and equitable healthcare system in Canada. Today we dive into an area where CSHP continuously provides expertise at a national level- drug shortages. 

CSHP plays a key role in advocating for mitigation strategies to minimize the impact of drug shortages on Canadians.  
 
We are proud attendees and contributors at federal agency stakeholder meetings. By attending and contributing to these meetings, we help the federal government improve approaches by offering solutions and advice that can make an impact both in the short- and long term. 

Throughout August CSHP has been providing feedback and amplifying the voice of hospital pharmacy on drug shortages. More specifically, on August 2 Rita Dhami, CPO attended a drug shortage meeting on Hydrocortisone Injections. 
 
On August 22, CPO Rita Dhami has been invited to attend a Roundtable on improving access to health products in Canada with the recently appointed Minister of Health, the Hon. Mark Holland.  
 
Additionally, our professional practice team is working on their consultation submission to the Health Canada Drug Shortages Task Force where they will be providing insight into what aspects of healthcare should be invested in for the 2023 budget. They will be commenting on the following four pillars:  

  • Improved communication and transparency 
  • Maintaining an agile regulatory toolbox 
  • Greater supply chain visibility 
  • Enhanced response to supply and demand 

Have a question about Advocacy in Action or CSHP's advocacy and consultation work?
Reach out to our professional practice team!   

August 15, 2023
Advocacy in Action - August 15

Latest News

Advocacy in Action: August 1

August 1, 2023
 
 

June 6, Choosing Wisely Canada

CPO Rita Dhami and Practice Specialist Kiet-Nghi Cao participated in the Annual Meeting of the Societies with key partners across multiple disciplines. The focus of this year’s meeting was on sustainable practices. 

June 16, Health Canada Health Products Supply Chain Advisory Committee with Health Minister Duclos

CEO Jody Ciufo and Rita Dhami shared insights on drug shortage solutions.

June 19, NAPRA Pharmacy Practice Meeting  

Rita Dhami and CSHP Vision Task Force Lead Mary Gunther participated in a valuable engagement session with key partners across the pharmacy sector on the implementation of the NAPRA Principles of Professionalism into pharmacy practice. 

July 27, Health Canada/Public Health Agency of Canada Pharmaceutical Drugs Program (PDP)   

CPO Rita Dhami was able to share CSHP perspectives with PHAC on drug shortages, assessment of climate change impacts, and the National Pharmacare Strategy.  

Ongoing, Health Canada Drug Shortages  

CSHP is providing weekly feedback and amplifying the voice of hospital pharmacy on drug shortages. 


CSHP is taking action to build a safer, more sustainable, and equitable healthcare system in Canada. Through active engagement in various committees, forums, and partnerships, CSHP strives to address drug shortages, enhance pharmaceutical safety, advance a National Pharmacare Strategy, promote pharmacy professionalism, and embrace sustainable practices. 

Addressing Drug Shortages

CSHP plays a key role in advocating for mitigation strategies to minimize the impact of drug shortages on Canadians. We are proud attendees and contributors at federal agency stakeholder meetings. We offer solutions and advice to the federal government on how they can best alter and implement their approaches in both the short and long term. CPO Rita Dhami has offered feedback on the federal government’s Pharmaceutical Drugs Program (PDP). She recognized the role PDP has in maintaining the safety, efficacy, and quality of regulation and while it has also vastly improved transparency in areas like regulatory processes or drug supply, there is still work to be done. Namely, she identified the opportunity for early identification of supply chain disruptions and for shortening the runway of foreign supply. The focus on drug shortages is likely to soon expand to other shortages in the health care industry, including medical equipment and nutritional supplements. 

Advancing National Pharmacare Strategy

It has long been CSHP’s belief that the Canadian healthcare system must be restructured so that Canadians have equitable access to evidence-based, effective, medically necessary drugs, including access to the expertise of pharmacists, regardless of their care setting or their ability to pay. This stance was affirmed by CPO Rita Dhami in her recent discussions with Health Canada/Public Health Agency of Canada, where she advocated for a transparent National Pharmacare Strategy that harmonizes access and coverage of drugs across Canada. 

Integrating Professionalism Principles into Pharmacy Practice

We have aligned ourselves with the need for professionalism in pharmacy practice as set out by the National Association of Pharmacy Regulatory Authorities (NAPRA). The embracing of professionalism not only improves the working conditions for pharmacy team members but also improves the level and the quality of care that health care practitioners can offer their patients. We have offered our perspective on how it can assist in the dissemination, uptake, and implementation of these principles in the daily work of collaborative healthcare environments especially as they align with the mission of CSHP’s Vision for Pharmacy Task Force. CSHP looks forward to further communication and collaboration on this topic. 

Promoting Sustainable Pharmacy Practices

CSHP is dedicated to promoting sustainable practices within the health care sector. 
 
CSHP continues to accomplish this goal through attending stakeholder meetings where we can amplify our current efforts and advocacy for sustainability in pharmacy, including the push for the assessment of climate change impacts in the regulatory process in addition to highlighting the work of CSHP’s Sustainability task force. These meetings provide CSHP insight into our healthcare peers sustainability activity. We take away inspiration and concepts to apply to hospital pharmacy.  
 
Soon, CSHP will be refreshing our Choosing Wisely Canada Hospital Pharmacy recommendations. These updated recommendations will balance quality pharmacy practice as well as environmental consciousness and will include a ‘green leaf’ label where sustainability practices are in play. 

Have a question about Advocacy in Action or CSHP's advocacy and consultation work?
Reach out to our professional practice team!   

August 01, 2023
Advocacy in Action - August 1

Latest News

Sustainability in Pharmacy Task Force Recommendations Consultation Request

August, 2023
 
 
 
In January 2023, the CSHP Board struck a task force to research, identify and prioritize goals to address the climate change crisis.  The CSHP Sustainability in Pharmacy Task Force has led this work with significant collaboration from the Canadian Association of Pharmacy for the Environment (CAPhE). The draft recommendations are available for review and comment. Review the attached document ‘CSHP Sustainability in Pharmacy Recommendations’ and complete the survey: https://ubc.ca1.qualtrics.com/jfe/form/SV_cu6rgu0mynTW9EO.

Survey will be available until: Aug 25th, 2023. It will take approximately 20-30 minutes to complete.

Thank you for your participation in this important work! For any questions related to the survey, please reach out to our Co-Chairs Karen Dahri (karen.dahri@vch.ca) or Kristen Tangedal (kirsten.tangedal@saskhealthauthority.ca). 
August 01, 2023
Sustainability in Pharmacy Task Force Recommendations Consultation Request

Latest News

CSHP is searching for our next CPRB Coordinator

April 3, 2023
 
 

Coordinator, Canadian Pharmacy Residency Board

 
 

Position Summary

 

The incumbent will coordinate the work of the Canadian Pharmacy Residency Board (CPRB) and CPRB-accredited pharmacy residency programs which operate within the Canadian Society of Hospital Pharmacists. The Coordinator is responsible for the operations of the CPRB Board and committee meetings; the workflows of the accreditation, standards and the Pharmacy and Residency Application and Matching Service (PRAMS) programs; and the information system and communications functions required. This role reports directly to the Chief Pharmacy Officer, but requires close collaboration with the Chair, as well as other CPRB members and sub-committee members.

 

Responsibilities

  • Administer and support the operations of the Canadian Pharmacy Residency Board, its members and committees.
  • Organize the workflow of pharmacy residency program support, including accreditation, standards-setting, and the residency matching program.
  • Handle communications with a variety of internal and external stakeholders and be responsible for the relevant information systems.

 

Partial list of duties

CPRB board and committee operations

  • Manage all meeting logistics, including developing board and committee work plans and calendars, timely preparation and distribution of agendas, notifications, and advance reading material.
  • Attend and serve as a recording secretary for board and as required, committee meetings, preparing and maintaining minutes, policies, and other public and confidential documents of the board and its committees in a timely manner.
  • Communicate all decisions, actions, directives, and important information following board and committee meetings to the appropriate individuals or stakeholders.
  • Anticipate and follow up on outstanding agenda items, taking action to ensure information is provided to the board and committee members.
  • Liaise with CSHP Board administration to support CPRB’s Chair’s participation in meetings and draft written report and PowerPoint presentations for CSHP Board meetings.

Program Management

  • Compile and report key metrics regarding residency programs (e.g., number of programs, residency programs, and ratio of applicants to matched applicants)
  • Annually update CPRB documents, in collaboration with CPRB members (e.g., CPRB Accreditation Standards, Policy and Procedures, Strategic Business Plan) and coordinate translation
  • Accreditation Surveys
    • Maintain and update survey schedule and documents as required
    • Act as liaison between residency programs and CPRB surveyors on survey processes and accreditation
    • Ensure that accreditation decisions are communicated promptly and accurately through program survey letters and formal final survey reports
  • Liaise with external information services provider regarding enhancements and updates to PRAMS program
  • Communicate with applicants and programs on application and matching process
  • Contribute to the resolution of issues that arise during the application-matching process
  • Standards
  • Accreditation Surveys
    • Maintain strict version control and updates for CRPB Accreditation Standards
    • Ensure annual updates are translated and published to the CPRB website

Communications and Information Systems 

  • Act as the CSHP office point of contact for accredited pharmacy residency programs, program applicants, and CPRB members
  • Maintain the CPRB section of the CSHP website
  • Manage Sharepoint site for CPRB and committees, including membership rosters, documents, permissions, etc.
  • Liaise with appropriate CSHP staff on material for Interactions, Avenues for Education, Annual Reports, event scheduling, publicity, and promotions. 

Administrative

    • Assist with and verify travel expense claims for volunteers and staff
    • Liaise with finance for invoicing and payments
    • Handle logistical arrangements and/or liaise with other CSHP staff for webinars and special events, such as the Student and Residency Networking event

     

    Education

    • Postsecondary education required. Equivalent experience will also be accepted.  

     

    Skills and Experience

    • 5 years of senior administrative roles including specialized knowledge of board governance procedures and project management experience, ideally in a non-for-profit organization
    • Extensive computer and software skills, especially in Excel, PowerPoint, Sharepoint and database programs
    • Accurate, detail-oriented, and high-quality outputs
    • Multi-tasking skills and ability to be flexible when priorities shift
    • Excellent oral and written communication skills
    • Proactive problem-solving skills
    • Ability to work with confidential and sensitive matters
    • Fluency in both official languages an asset

     

    Location and travel

    • The position can be housed in the CSHP National Office in Ottawa or staffed remotely.
    • Occasional travel within Canada is required.

    Applications will be accepted on a rolling basis until the position is filled.

    About the CPRB:
    An affiliated board of the Canadian Society of Hospital Pharmacists, the Canadian Pharmacy Residency Board (CPRB) establishes standards and conducts accreditation surveys of pharmacy residency training programs in Canada. It also establishes policies and procedures that support those processes and develops education and research initiatives related to residency programs and residency training.

     

    April 03, 2023
    CSHP is searching for our next CPRB Coordinator

    Latest News

    CSHP is searching for our next Chief Pharmacy Officer

    March 31, 2023
     
     
     
    CSHP's inaugural Chief Pharmacy Officer Christina Cella is stepping down at the end of April after nearly four years in the job. Christina has distinguished herself and CSHP by setting a high standard for the position. We are coming to the end of our first strategic plan for the renewal and future sustainability of the Society and it has been an unqualified success. Christina has played a large role in this. 

    CEO Jody Ciufo says, “Christina made significant contributions during her time with us – the creation of an instant webinar program during the first crucial months of COVID, the establishment of a formal professional practice team and her eloquent media presence in advocacy efforts surrounding COVID, drug shortages and US importation. CSHP members celebrated seeing hospital pharmacy reflected widely in Christina’s comments across the county.” 

    “I’ve been a dedicated CSHP volunteer from my earliest days at school,” says Christina. “CSHP will always be a part of my career and my love of hospital pharmacy.”

    The search for CSHP’s next CPO has begun. Details on the position are below and the application deadline is April 28. 


    Chief Pharmacy Officer

     
     

    Position Summary

     

    CSHP is seeking a leading pharmacist to become its next Chief Pharmacy Officer. This senior leadership position is instrumental in shaping the future of pharmacy practice in hospitals and other related healthcare organizations in Canada. Reporting to the Chief Executive Officer, the Chief Pharmacy Officer (CPO) will be responsible and accountable for meeting the pharmacy and professional practice objectives within CSHP’s strategic plan. You will have autonomy and authority to deliver professional practice services, products, and initiatives within the policy framework established by the Board and the CEO. The CPO will be the in-house go-to for all things pharmacy.

    You will lead the Professional Practice team and be responsible for the development of our suite of professional resources for CSHP members, policy positions, continuing education, best practices, consultations, research and knowledge translation. Your team supports a variety of CSHP committees and task forces, as well as the work of the affiliated Canadian Pharmacy Residency Board and the Hospital Pharmacy Survey in Canada Board. 

    As the successful candidate, your leadership skills will ensure excellence in the delivery of projects that are of strategic importance to CSHP. You have a demonstrated record of inspiring and supporting your team and volunteers to higher levels of performance and excellence in patient care and safety. You understand issues that are relevant to practice, from the grassroots level of hospital pharmacy to those at the highest levels of the healthcare system. Collaborative and connected, you will be comfortable representing CSHP on external committees/advisory groups, in the media, with industry and to government departments and elected officials.

    Licensed to practice pharmacy in Canada, you are a senior pharmacist who has practiced in a hospital or collaborative setting, along with management experience in a hospital, association, regulatory authority, government, health administration or academic institution. Volunteer experience demonstrating your interest in giving back to the pharmacy profession is a definite asset.

    Major Job Responsibilities

     

    Practice Advancement

    • Leads and coordinates organization-wide efforts to advance pharmacy practice and address critical practice issues, such as scope of practice, standards, guidelines, competencies, etc
    • Monitors health care and pharmacy practice trends to present issues to the Board and relevant committees and implement resulting strategic direction
    • Manages the implementation of the Canadian Pharmacy Residency Board strategic objectives 
    • Oversees the operation of the Pharmacy Specialty Networks and realizing gains in usage, relevance and functionality; advancing specialty areas prioritized by the Board 
    • Operationalizes CSHP’s expanded membership value for registered pharmacy technicians by creating targeted programs and services in this area. 
    • Enables data-driven policy development by ensuring the collection of statistics on workforce, licensure, graduates, residencies and other relevant metrics for the profession and managing all practice-related surveys

     

    Professional Development

    • Grows CSHP’s professional development program into a comprehensive educational enterprise that meets member needs in content, relevance and delivery options
    • Analyzes current offerings of CSHP and other providers in education and training and develops new content to fill gaps
    • Oversees pharmacy elements of the annual national conference including volunteer committees, thematic programming, speaker selection, research integration, etc; collaborates with other staff on various elements of the conference

     

    Policy & Advocacy

    • Monitors federal legislation, regulations and policy that affect pharmacy in hospitals and other collaborative settings
    • Coordinates response to formal consultations on federal government legislation and regulations through CSHP committee and member feedback
    • Leads CSHP’s consultation process to solicit input from members and stakeholders to ensure representation from across the country
    • Tracks trends in provincial legislation, regulations and policy; coordinating national responses and assisting provincial efforts as appropriate
    • Represents CSHP on various external boards, committees, task forces as required 
    • Supports CSHP advocacy campaigns through policy advice, professional content, external outreach

    CSHP Innovation
    • Supports the CEO in strengthening CSHP’s shift toward increasing non-dues revenue by improving the returns on existing programs and exploring new entrepreneurial options 
    • Integrates a member-centric vision throughout professional practice programs and views future initiatives through this lens 
    • Develops business plans for new offerings and tracks progress in achieving targets.

    Functional responsibilities
    • Prepares annual budgets for the professional practice department and initiatives and is responsible for budgetary performance
    • Acts as a key contributor to the CSHP strategic plan, prepares goals and objectives for professional practice, and is accountable for performance in these areas 
    • Responsible for setting employee performance objectives, clearly defining duties, and conducting performance reviews for direct reports
    • Identifies information technology requirements for program initiatives
    • As a senior leader, contributes to the positive, productive and supportive office environment
    • As part of the management team, advises the CEO on policies, overall budgets, organizational structure, capital decisions, and technology.

     

    Qualifications

    • Licensed to practice pharmacy in Canada and in good standing with relevant regulatory college. 
    • Five or more year of pharmacy practice in a hospital or collaborative setting.
    • Management experience in a hospital, association, government, health administration or academic institution.
    • A master’s degree in administration or advanced degree in pharmacy. 
    • Completion of a hospital pharmacy practice residency is an asset.
    • Superior written and oral skills in English.
    • Fluency in French is an asset.

     

    Considerations

    • This position is remote 
    • Travel is required approximately four times per year.
    • CSHP will consider candidates on a leave of absence from an existing position for a minimum of two years.

     

    Remuneration

    • CSHP offers a substantial salary and benefit package including:
      • Dental care
      • Extended health care
      • RRSP match
      • Employee assistance program
      • Disability and life insurance
      • Work from home

       

    How to apply

    We hire top talent, recognizing that our accomplishments are achieved through the commitment of dedicated individuals. Please email your cover letter and résumé to Jody Ciufo, Chief Executive Officer, at jciufo@cshp.ca at your earliest convenience, but no later than April 28, 2023. 

    About the Canadian Society of Hospital Pharmacists
    The Canadian Society of Hospital Pharmacists is the national voluntary organization of pharmacists and pharmacy technicians committed to patient care through the advancement of safe, effective medication use in hospitals and other collaborative healthcare settings. CSHP supports its 3700-plus members and individual supporters through advocacy, education, information sharing, promotion of best practices, facilitation of research, and recognition of excellence.

    Please note: We thank all applicants for their interest in this position. However, only those selected for an interview will be contacted. 

     Apply now




     

     
     
    March 31, 2023
    CSHP is searching for our next Chief Pharmacy Officer

    Latest News

    Black History Month: Pharmacy resources 2023

    February 16, 2023
     


    In honour of Black History Month this February, CSHP offers a collection of resources for pharmacy practice, celebrations, and advocacy all year round.
     

    Resources

    • Then, read the two incredible issues that touch on anti-Black racism, as recommended by the author, from Oct. 24, 2022, as well as Oct. 31, 2022.
    • Check out a clinical handbook of signs and symptoms in Black and brown skin: “Mind the Gap”.

     

    February 16, 2023
    Black History Month: Pharmacy resources 2023

    Latest News

    Tramadol amendments: CSHP advocacy at work

    April 07, 2022

    CSHP is honoured to advocate for federal policies that support safe and effective medication use. Recently, we saw the impact of CSHP’s commentary on the reclassification of tramadol, an opioid analgesic, as a controlled substance.   

    In 2019, Health Canada consulted CSHP along with other stakeholders and experts regarding proposals to remove tramadol from the Prescription Drug List. CSHP advocated in support of these amendments, stating that they would “strengthen pharmacovigilance of tramadol” and “strengthen the controls to prevent and detect diversion activities.”  Although tramadol can provide effective pain relief for some patients, it is suspected to have contributed to 18 reported deaths in Canada between 2006 and 2017. CSHP therefore supported changes that would help reduce problematic substance use and heighten regulation of this drug.  

    In 2021 Health Canada removed tramadol from the Prescription Drug List and listed it as a controlled substance and narcotic in Schedule I of the Controlled Drugs and Substances Act and the Narcotic Control Regulations. These changes came into effect on March 31, 2022. CSHP is proud to have participated in efforts to protect access to tramadol for patients who need it, while helping reduce harm from problematic substance use.   

    April 07, 2022
    Tramadol amendments: CSHP advocacy at work

    Latest News

    Drug shortages: FAQ

    March 24, 2022

     


    Drug Shortages

    Drug shortages are a global issue that can significantly affect patient outcomes. CSHP plays a key role in advocating for mitigation strategies to minimize the impact of drug shortages on Canadians. Keep reading to learn more about the impacts of drug shortages, and ways CSHP and other stakeholders work to protect Canada’s healthcare system.

     
    What are the main reasons for drug shortages?

    Causes of drug shortages are multifactorial and can include the following, either alone or in combination:

    • Shortage of raw materials to make API (active pharmaceutical ingredient), excipients or packaging materials
    • Manufacturing difficulties and disruption in supply chain
    • Regulatory issues: policies, communication with stakeholders, implementation of safety and efficacy standards.
    • Voluntary recalls
    • Globalization, mergers, and acquisitions of drug companies
    • Supply and demand issues
    • Logistical issues: transportation, natural disasters, contamination, management incompetency

     
    What are the impacts of drug shortages?

    Drug shortages and resulting issues oblige members of the healthcare team to quickly use their problem-solving skills. When encountering a drug shortage, the pharmacy team may need to find appropriate therapeutic substitutes, determine different concentrations of the drug, and adjust strengths or dosage forms of the same medication. The team may also communicate with other healthcare professionals and source scarce drugs from other hospitals or suppliers. The table below highlights the economic and clinical consequences of drug shortages.

    Impact of drug shortage

    Potential consequences

    Economic

    • Increased hospital expenses
    • Increased budget for stakeholders
    • Increased risk of drug shortages for alternative drugs
    • Increased out-of-pocket expenses
    • Importation of medication from other countries

    Clinical

    • Increased medication safety incidents
    • Compromised clinical patient outcomes
    • Reduced clinical work with patients
    • Strained professional relationships with healthcare professionals and patients
    • Potential for patients to seek counterfeit medication

     
    How does CSHP advocate to prevent and mitigate the impacts of drug shortages nationally?

    One of CSHP’s fundamental values for pharmacy practice has been advocating for patient safety. Our objective is to minimize drug shortages and mitigate their effects by continuing to actively collaborate with governments, industry, distributors, wholesalers, major corporations, other healthcare providers, and stakeholders. CSHP’s efforts include the following examples:

    Health Canada consultations

    CSHP participates in calls with Health Canada and other stakeholders (including provinces and territories, manufacturers, other healthcare associations, and group purchasing organizations). CSHP’s roles are to:

    • Help determine whether the current drug shortage should be considered critical
    • Share this information with members
    • Help the Canadian population understand the decision-making process behind these mitigation strategies.

    Membership in the Alliance for Safe Online Pharmacies Canada

    As a member of Alliance for Safe Online Pharmacies (ASOP) Canada, CSHP collaborates with other stakeholders to:

    • Advocate to prevent American federal and state legislation proposals to import drugs from Canada.
    • Prepare official submissions to federal legislatures concerning FDA’s Proposal on Importation of Prescription Drugs.

    Membership in the Multi-Stakeholder Steering Committee on Drug Shortages (MSSC)

    As an active member of the Multi-Stakeholder Steering Committee on Drug Shortages (MSSC), CSHP’s roles have been to:

    • Actively participate in public reporting of drug shortages (since 2011)
    • Collaborate with stakeholders to draft a letter requesting that Canada’s drug supply be protected against US importation proposals and legislation
    • Help create reference documents regarding drug shortages (attached below in Question #6 under MSSC References).
    • Participate in the International Summit on Medicines Shortages with both the International Pharmaceutical Federation and the Canadian Pharmacists Association

     

    What other stakeholders are involved in mitigating drug shortages, and what are their respective roles?

    Stakeholders

    Roles

    Hospital pharmacy managers and technicians

    • Finding appropriate therapeutic alternatives
      • Substituting another medication in the same therapeutic class as the scarce drug 
      • Substituting medication in a different therapeutic class from the scarce drug, but with a similar mechanism of action
      • Determining different pack sizes or concentrations
      • Determining different strengths or dosage forms of backordered medication
      • Communicating with other healthcare professionals and suppliers to obtain medication
      • Compounding medications if possible
    • Determining prioritization of patient populations for distribution of scarce medication  
    • Notifying other stakeholders of updates on drug shortages (including high-alert medication warnings)
    • Educating patients

    Group purchasing organizations

     

    • Serving as a link between hospitals and suppliers
    • Promoting sharing of documents from hospitals such as guidance on drug shortages, mitigation strategies, and suggestions for therapeutic alternatives
    • Ensuring a fair allocation of scarce medication to as many hospitals as possible
    • Requesting protective allocations if a medication is at risk of being in shortage

    Manufacturers

     

    • Reporting any foreseeable drug shortages to Health Canada
    • Participating in multi-stakeholder calls
    • Communicating with global partners to ensure additional medication for Canadian drug supply  

    Health Canada

     

    • Health Canada’s Drug Shortages Division (DSD) plays a key role in responding to drug shortages: Coordinating information sharing between impacted groups, implementing mitigation strategies, and assessing potential impact of shortages
    • Expediting Establishment License Review, Submission Review, and Lot Release for medications
    • Providing guidance on access to unauthorized drugs through the Special Access Programme
    • In exceptional circumstances, releasing an interim order from Minister of Health to help safeguard Canadian drug supply

     

     

    How can CSHP members receive updates about drug shortages? 

    CSHP offers a free Pharmacy Specialty Network (PSN) for all CSHP members to stay updated on current drug shortages. This is a forum for pharmacy staff to seek support and suggestions from peers facing similar challenges with managing drug shortages in their institutions. Topics of discussion may include, but are not limited to: therapeutic alternatives, preservation strategies, obtaining SAP products, look-alike alerts, and drug shortage updates. 

    To access to the CSHP Drug Shortages PSN, click here. Alternatively, please follow these steps: Member Centre > Pharmacy Specialty Networks > Create Account or Log-In to QID > Search Communities > Drug Shortages PSN

     

    Where else can I seek up-to-date information on drug shortages?

    Drug Shortages Canada / Pénuries de médicaments Canada

    Drug Shortages in Canada (Government of Canada)

    House of Commons report on Drug Supply in Canada: A Multistakeholder Responsibility 

    Canadian Drug Shortage website

    US Food and Drug Administration’s Report on Drug Shortages

    MSSC resources:

    Multi-Stakeholder Toolkit: A Toolkit for Improved Understanding and Transparency of Drug Shortage Response in Canada

    Protocol for the Notification and Communication of Drug Shortages

    Guidance Document to Mitigate Drug Shortages through Contracting and Procurement

    Preventing Drug Shortages: Identifying Risks and Strategies to Address Manufacturing-Related Drug Shortages in Canada



     References 

    Adams C. Understanding Drug Shortages During a Pandemic. Hospital News [Internet]. 2020 [cited 14 March 2022]. Available from: https://hospitalnews.com/understanding-drug-shortages-during-a-pandemic-2/

    Drug Shortages. Canadian Society of Hospital Pharmacists (CSHP) [Internet]. 2020 [cited 14 March 2022]. Available from: https://www.cshp.ca/site/adv/advocacy/drug-shortages?nav=advocacy

    Shukar S, Zahoor F, Hayat K, Saeed A, Gillani AH, Omer S, Hu S, Babar ZU, Fang Y, Yang C. Drug Shortage: Causes, Impact, and Mitigation Strategies. Frontiers in pharmacology. 2021;12.

    Drug Shortages Continue to Compromise Patient Care. Institute for Safe Medication Practices (ISMP) [Internet]. 11 January 2018. [cited 16 March 2022]. Available from: https://www.ismp.org/resources/drug-shortages-continue-compromise-patient-care

     

    March 24, 2022
    Drug shortages: FAQ

    Latest News

    ICYMI: PAM 2022 highlights

    March 23, 2022


    Thanks to your efforts and enthusiasm, it's been a vibrant and fun-filled Pharmacy Appreciation Month! In case you missed it, keep reading for a round-up of some of our favourite moments of #PAM2022 so far. 

    1. Listen to CSHP President Zack Dumont's interview with HealthPRO. Zack highlighted the valuable work of hospital pharmacy "unsung heroes," the challenges we face, and big practice changes on the horizon. Watch the conversation here.
    2. Read a Victoria Hospitals Foundation interview with Sean Spina, CSHP President-Elect. Sean shared his perspective on hospital pharmacy's essential role in the Hospital at Home program, and the importance of evidence-based advocacy: "I have dedicated much of my career to using data to advocate for recognition in the healthcare system of the essential role that our teams play in care delivery." Read the interview here.
    3. Check out a recent interview with CSHP's 1999 Distinguished Service Award winner Bonnie Salsman, who reflects on her legendary pharmacy career and the many changes she's witnessed in the profession. See the conversation here.
    4. Read the inspiring story of two young patients, ages 6 and 7, whose debilitating drug-resistant epilepsy was treated with life-changing medications thanks to a pharmacy team at Hamilton Health Services. Read the story here.
    5. Check out all the amazing stories and hospital pharmacy love on social media: Tributes to pharmacy teams from hospitals, kudos and special shoutouts, advocacy highlights, and your awesome lists of reasons you're proud to be a hospital pharmacy professional. 







    March 23, 2022
    ICYMI: PAM 2022 highlights

    Latest News

    Three ways for pharmacy professionals to support healthcare in Ukraine

    March 11, 2022

     


    As pharmacy professionals, CSHP members are committed to safe, equitable access to healthcare for patients around the world. With tragic events unfolding in Ukraine, CSHP members and partners have identified three ways to support pharmaceutical care for Ukrainian people impacted by violence.  

      

    HPIC has organized an emergency fundraising campaign aiming to get medicines into the hands of Ukrainians in need, either in Ukraine or in countries where they are seeking refuge. HPIC is well positioned to quickly mobilize donations and medicines. Donate online here. 

     

    The Canada-Ukraine Foundation is collecting donations for the Ukraine Humanitarian Appeal, which, according to their website, has already deployed approximately $550,000 CAD in aid to provide food, shelter, and medicine to Ukrainians in need. Donate online here. 

     

    The International Pharmaceutical Federation (FIP) is collecting donations in solidarity with our colleagues in Ukraine, the All-Ukrainian Pharmaceutical Chamber (AUPC), to help maintain access to pharmaceutical care. According to Oleg Klimov, chairman of AUPC, “Pharmacists in Ukraine continue to fulfill their mission in patient care . . . but now work with bulletproof vests over their white coats. . . The pharmacy is one of the most accessible places for the general population where it is possible to receive first aid.” Donate online here 

    March 11, 2022
    Three ways for pharmacy professionals to support healthcare in Ukraine

    Latest News

    CSHP’s contributions to the Best Brains Exchange on antimicrobial business models

    March 11, 2022

    As part of CSHP’s mission to represent hospital pharmacy at the national level, CSHP recently participated in Health Canada’s Best Brains Exchange on antimicrobial business models. Stakeholders gathered to discuss the global market failure of antimicrobials, and to explore potential pull incentive options that could increase access in Canada.

    In discussions, participants emphasized that “stewardship principles should be built into any pull incentive model as there is a need to preserve the effectiveness of the high value of antimicrobials.” Participants also highlighted the importance of engaging with all relevant Canadian pharmacy stakeholders in developing a pilot model.   

    This was an exciting, collaborative opportunity to share the hospital pharmacy perspective with our peers as we work together to innovate antimicrobial business models. To read Health Canada’s full summary of the meeting, click here

     

    March 11, 2022
    CSHP’s contributions to the Best Brains Exchange on antimicrobial business models